BIOMAT Database Logo BIOMAT Database Logo

[Efficacy of treatment with 25 OH D3 in a case of chronic hypoparathyroidism slightly responsive to treatment with vitamin D]. 1982

F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani

UI MeSH Term Description Entries
D007011 Hypoparathyroidism A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone. Idiopathic Hypoparathyroidism,Hypoparathyroidism, Idiopathic
D002112 Calcifediol The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. 25-Hydroxycholecalciferol,25-Hydroxyvitamin D 3,25-Hydroxycholecalciferol Monohydrate,25-Hydroxyvitamin D3,Calcidiol,Calcifediol Anhydrous,Calcifediol, (3 alpha,5Z,7E)-Isomer,Calcifediol, (3 beta,5E,7E)-Isomer,Calderol,Dedrogyl,Hidroferol,25 Hydroxycholecalciferol,25 Hydroxycholecalciferol Monohydrate,25 Hydroxyvitamin D 3,25 Hydroxyvitamin D3,Anhydrous, Calcifediol,Monohydrate, 25-Hydroxycholecalciferol
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014807 Vitamin D A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.

Related Publications

F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani
Efficacy of two vitamin D immunoassays to detect 25-OH vitamin D2 and D3.
November 2019, Practical laboratory medicine,
F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani
[Vitamin-D dependent rickets: report of a case and efficacy of treatment with 25 OH-vitamin D].
January 1982, La Pediatria,
F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani
[Primary hypoparathyroidism resistant to treatment with vitamin D3, 25-hydroxycholecalciferol and dihydrotachysterol. Efficacy of treatment with 1 alpha,25-dihyroxycholecalciferol].
April 1983, Medicina clinica,
F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani
Case report: hypoparathyroidism and iron storage disease. Treatment with 25-hydroxy-vitamin D3.
January 1978, The American journal of the medical sciences,
F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani
What's in a name--25(OH)D or 25(OH)D3?
January 2004, The National medical journal of India,
F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani
Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol.
August 1970, Archives of internal medicine,
F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani
Blunted serum 25(OH)D response to vitamin D3 supplementation in children with autism.
July 2020, Nutritional neuroscience,
F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani
Serum 25(OH)D response to vitamin D3 supplementation: a meta-regression analysis.
September 2014, Nutrition (Burbank, Los Angeles County, Calif.),
F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani
Overreporting of vitamin D deficiency with the Roche Elecsys Vitamin D3 (25-OH) method.
June 2011, Pathology,
F Cataldo, and E Scotto, and T De Gregorio, and A Albeggiani
Association of Dietary Vitamin D Intake, Serum 25(OH)D3, 25(OH)D2 with Cognitive Performance in the Elderly.
September 2021, Nutrients,
Copied contents to your clipboard!